Uchtenhagen A
Psychiatrische Universitätsklinik Zürich, Sektor West und zentrale sozialpsychiatrische Dienste, Zürich.
Schweiz Arch Neurol Psychiatr (1985). 1995;146(5):215-23.
A review of epidemiological data regarding the prevalence of substance abuse in schizophrenia and vice versa points out differences which are hard to interpret, owing to inconsistent sampling procedures and to the application of different diagnostic criteria. Stimulant abuse in schizophrenics has apparently increased over the years, eventually alcoholic abuse, whereas no increase is evidenced for cannabis abuse. Patients with dual diagnosis have an increased risk for morbidity and mortality, for psychotic relapse and for social disintegration. No increased risk for schizophrenic psychosis is found for drug abusers. Possible explanations why schizophrenics could show an increased susceptibility to become substance abusers are discussed, and therapeutic recommendations added.
一项关于精神分裂症中物质滥用患病率的流行病学数据回顾,以及反之关于物质滥用中精神分裂症患病率的回顾指出,由于抽样程序不一致和不同诊断标准的应用,存在难以解释的差异。多年来,精神分裂症患者中兴奋剂滥用明显增加,最终是酒精滥用,而大麻滥用未见增加。双重诊断的患者发病和死亡风险增加,精神病复发风险和社会解体风险增加。未发现药物滥用者患精神分裂症性精神病的风险增加。文中讨论了精神分裂症患者可能更易成为物质滥用者的原因,并给出了治疗建议。